Dag Morten Dalen

Dag Morten Dalen is the provost and senior vice president of BI Norwegian Business School, with the overall responsibility for the quality of degree programmes at bachelor, master, phd and executive level. Dalen holds a professor position in economics, and has published widely in the area of industrial organization and industry regulation.

In his more recent research Dalen has been studying competition, prescription choices and regulation in pharmaceutical markets Dalen has extensive consulting experience from projects with ministries, regulatory authorities and private companies, covering topics related to competition policy, regulation of network industries, health economics and quality assurance of larger public investment projects.

In 1997-1998 Dalen worked full-time for the Parliamentary Commission for the investigation of the Norwegian Banking Crisis, and in 2004-2005 he was a member of the Norwegian Ministry of Administration and Labour Expert Commission on Competition between Public and Private Enterprises.

Research interests

Industrial economics, Economics of regulation, Pharmaceutical markets

ACADEMIC DEGREES

• 1996 University of Oslo Ph.D Dr. Polit.
• 1991 University of Oslo Master Cand. Oecon

WORK EXPERIENCE

• 2010 - Present BI Norwegian Business School Provost - Senior Vice President
• 2006 - Present BI Norwegian Business School Associate Dean, MSc in Business and Economics
• 2004 - Present BI Norwegian Business School Professor
• 2006 - 2007 BI Norwegian Business School Acting Head of Department
• 1998 - 2004 BI Norwegian Business School Associate Professor
• 1999 - 2000 Central Bank of Norway Senior advisor (part time)
• 1997 - 1998 Stortinget (The Norwegian Parliament) Advisor
• 1996 - 1998 SNF-Oslo Researcher
• 1992 - 1996 University of Oslo, Dept. of Economics Research fellow

SCIENTIFIC ARTICLES

• Dalen, Dag Morten; Locatelli, Marilena; Sorisio, Enrico; Strøm, Steinar. Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?. Applied Economics and Finance 2014 ;Volume 1.(1) BI FRISCH
• Brekke, Kurt; Dalen, Dag Morten; Holmås, Tor Helge. Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs. European Journal of Health Economics 2013 ;Volume 15.(9) p. 937-951BI NHH UNI
• Brekke, Kurt; Dalen, Dag Morten; Strøm, Steinar. Should pharmaceutical costs be curbed?. Nordic Economic Policy Review 2012; Volume 2. p. 1-27 BI FRISCH NHH
• Dalen, Dag Morten; Moen, Espen R. Ownership and Cost-Sharing Contracts. Australian Economic Papers 2012 ;Volume 51.(3) p. 134-146 BI
• Dalen, Dag Morten; Furu, Kari; Locatelli, Marilena; Strøm, Steinar. Generic substitution: micro evidence from register data in Norway. European Journal of Health Economics 2011 ;Volume 12.(1) p. 49-59
• Dalen, Dag Morten; Hoel, Michael Olaf; Strøm, Steinar. Markedsmakt og innovasjon på norsk sokkel. Samfunnsøkonomen 2011 ;Volume 65.(3) p. 40-45 BI UiO